Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA602036
`ESTTA Tracking number:
`05/02/2014
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`92057854
`Defendant
`Nutramarks, Inc.
`TIMOTHY P GETZOFF
`HOLLAND & HART LLP
`ONE BOULDER PLAZA, 1800 BROADWAY SUITE 300
`BOULDER, UT 80302
`UNITED STATES
`tgetzoff@hollandhart.com, jguy@hollandhart.com, docket@hollandhart.com, ej-
`cooper@hollandhart.com, rsheld@hollandhart.com
`Motion to Suspend for Civil Action
`Timothy P. Getzoff
`tgetzoff@hollandhart.com,jguy@hollandhart.com,docket@hollandhart.com
`/s/ Timothy P. Getzoff
`05/02/2014
`Renewed Motion to Suspend Proceedings.pdf(14052 bytes )
`Exh A.pdf(1378207 bytes )
`Exh B.pdf(209303 bytes )
`
`Proceeding
`Party
`
`Correspondence
`Address
`
`Submission
`Filer's Name
`Filer's e-mail
`Signature
`Date
`Attachments
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Registration No.: 4,184,983
`
`Mark: ALKAMAX
`
`Cancellation No.: 92057854
`
`
`
`)))))))))
`
`
`
`Bayer HealthCare LLC,
`
`Petitioner,
`
`
`
`
`v.
`
`NutraMarks, Inc.,
`
`Registrant.
`
`
`
`
`
`RENEWED MOTION TO SUSPEND PROCEEDINGS IN VIEW OF PENDING CIVIL
`ACTION PURSUANT TO TRADEMARK RULE 2.117(A)
`
`Registrant NutraMarks, Inc. (“NutraMarks”) moves pursuant to Trademark Rules
`
`2.117(a) and 2.127(a), and TBMP § 510.02(a) for suspension of the instant cancellation
`
`proceeding pending determination of a related federal civil action. This motion is identical to the
`
`motion previously filed, except that Registrant inadvertently omitted the Complaint in the
`
`underlying action, which is now attached.
`
`NutraMarks and Petitioner Bayer HealthCare LLC (“Bayer”) are involved in litigation in
`
`the United States District Court for the District of Utah, entitled Nutraceutical Corporation et al.
`
`v. Bayer Healthcare LLC, Civil Action No. 2:13-cv-00955-TC (the “Federal Action”). Because
`
`NutraMarks is concerned with both maintaining its registration and its real-world use of the same
`
`mark, it filed a Declaratory Judgment Complaint in order to resolve with certainty its rights to
`
`use its registered mark ALKAMAX. See Complaint for Declaratory Judgment filed on October
`
`17, 2013 (filed herewith as Exhibit A). Bayer filed its Answer to the Complaint and
`
`Counterclaim on April 9, 2014 (filed herewith as Exhibit B). The Federal Action involves the
`
`same parties, the same mark, and the same issues as those involved in the instant opposition
`
`

`
`proceedings, that is, whether a likelihood of confusion exists between NutraMarks’ ALKAMAX
`
`mark and Bayer’s asserted ALKA-SELTZER marks. In addition, in the Federal Action
`
`NutraMarks seeks an Order “enjoin[ing Bayer] and restrain[ing it] permanently from interfering
`
`with [NutraMarks’] use or registration of the ALKAMAX mark…and from opposing or
`
`otherwise objecting or seeking to cancel any of [NutraMarks’] federal registrations or
`
`applications for ALKAMAX based upon an alleged likelihood of confusion with ALKA-
`
`SELTZER.” See Complaint (Ex. A) at “Prayer for Relief.”
`
`Where the parties to a proceeding before the Board are involved in a civil action, the final
`
`determination of which will have a bearing on the proceeding before the Board, the TTAB
`
`proceedings should be suspended until final determination of the civil action. See 37 C.F.R. §
`
`2.117(a); The Other Telephone Company v. Connecticut National Telephone Company, Inc., 181
`
`U.S.P.Q. 125, 127 (T.T.A.B., Feb. 11, 1974); Miller v. B&H Foods, Inc., 209 U.S.P.Q. 357, 359
`
`(T.T.A.B. Jan. 5, 1981) (“[U]nder normal circumstances, where, as here, the civil action between
`
`the parties may be dispositive or have a direct bearing on the issues in a proceeding before the
`
`Board, it is the practice to suspend the proceeding before the Board to await the outcome of the
`
`civil action and to determine its effect on the issues in the action in the Patent and Trademark
`
`Office.”); see also The Toro Company v. Hardigg Industries, Inc., 187 U.S.P.Q. 689, 692
`
`(T.T.A.B. August 19, 1975) (granting motion to suspend based on a civil action seeking an
`
`injunction: “Thus there can be no doubt but that the final resolution of the civil action may be
`
`dispositive of the issues involved in this proceeding”).
`
`Here, the determination of the issues in the Federal Action will not only “have a bearing
`
`on,” but will be dispositive of these proceedings, so suspension is proper. See id. (“[W]hile the
`
`decision of the Federal District Court would be binding upon the Patent and Trademark Office, a
`
`2
`
`

`
`decision by the Board would not be binding or res judicata as to the issues before the court”).
`
`Suspension will also avoid the unnecessary expenditure of both the Board’s and each of the
`
`parties’ resources in litigating the same issue in two forums and will avoid the potential for
`
`inconsistent results.
`
`For the above reasons, NutraMarks respectfully requests that the Board grant this Motion
`
`and suspend the above-captioned opposition proceedings pending the final disposition of the
`
`Federal Action.
`
`
`
`Dated: May 2, 2014.
`
`
`
`
`
`
`
`
`
`
`
`/s/ Timothy S. Getzoff
`Timothy S. Getzoff
`Emily J. Cooper*
`tgetzoff@hollandhart.com
`ejcooper@hollandhart.com
`HOLLAND & HART LLP
`1800 Broadway, Suite 300
`Boulder, Colorado 80302
`Telephone: 303-473-2700
`Facsimile: 303-473-2720
`* Colorado Admission Pending; admitted
`in NY and MA
`
`
`
`
`
`ATTORNEYS FOR PETITIONER
`NUTRAMARKS, INC.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`

`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on May 2, 2014, I served a copy of the above Renewed Motion to
`
`Suspend Proceedings in View of Pending Civil Action Pursuant to Trademark Rule 2.117(a) to
`
`the following in the manner indicated below:
`
`
`
`Phillip Barengolts
`Elisabeth K. O’Neill
`PATTISHAL MCAULIFFE, NEWBURY,
`HILLARD & GERALDSON LLP
`200 S. Wacker Drive, Suite 2900
`Chicago, IL 60606
`(312) 554-8000
`
`Attorneys for Petitioner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`U.S. Mail, postage prepaid
`Electronic Mail
`Hand Delivery
`Fax
`
`
`
`
`
`
`
`
`
`
`
` /s/ Jane Guy
`
`
`
`
`
`
`
`
`
`6846475_1
`
`4
`
`

`
`Exhibit A
`Exhibit A
`
`
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 1 of 7
`
`Mark A. Miller, 9563
`mmiller@hollandhart.com
`HOLLAND & HART LLP
`222 S. Main Street, Suite 2200
`Salt Lake City, UT 84101
`Telephone: (801) 799-5800
`Facsimile: (801) 799-5700
`
`Timothy P. Getzoff, (pro hac vice pending)
`tgetzoff@hollandhart.com
`HOLLAND & HART LLP
`1800 Broadway, Suite 300
`Boulder, CO 80302
`Telephone: (303) 473-2700
`Facsimile: (303) 473-2720
`
`Attorneys for Plaintiffs
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF UTAH, CENTRAL DIVISION
`
`
`
`NUTRACEUTICAL CORPORATION,
`a Delaware corporation, and
`NUTRAMARKS, INC.,
`a Delaware corporation,
`
`Plaintiffs,
`
`
`
`
`vs.
`
`BAYER HEALTHCARE LLC,
`a Delaware limited liability company,
`
`
`
`
`
`COMPLAINT FOR DECLARATORY
`JUDGMENT OF NON-INFRINGEMENT
`
`
`
`Civil Case No. 2:13-cv-00955-TC
`
`Judge Tena Campbell
`
`
`
`Defendant.
`
`Plaintiffs Nutraceutical Corporation and NutraMarks, Inc., in support of their
`
`
`
`
`
`
`
`Complaint for Declaratory Judgment against Defendant, allege and state as follows:
`
`
`
`PARTIES
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 2 of 7
`
`1.
`
`Plaintiff Nutraceutical Corporation (“Nutraceutical”) is a Delaware corporation
`
`with a principal place of business at 1400 Kearns Blvd, Second Floor, Park City, Utah, 84060.
`
`2.
`
`Plaintiff NutraMarks, Inc. (“NutraMarks”) is a Delaware corporation with a
`
`principal place of business at 1500 Kearns Blvd, Suite B200, Park City, Utah, 84060.
`
`3.
`
`Defendant Bayer HealthCare LLC (“Bayer”) is a Delaware limited liability
`
`company with its principal place of business at 100 Bayer Road, Pittsburgh, Pennsylvania,
`
`15205.
`
`JURISDICTION AND VENUE
`
`4.
`
`This action arises and is brought under the Declaratory Judgment Act, 28 U.S.C.
`
`§§ 2201-2202, and the Trademark Act of July 5, 1946, as amended, commonly known as the
`
`Lanham Act, 15 U.S.C. § 1051, et seq. and Utah statutory and common law.
`
`5.
`
`Subject matter jurisdiction exists under 15 U.S.C. § 1121 and 28 U.S.C.
`
`§§ 1331, 1338, and 2201-2202.
`
`6.
`
`This Court possesses personal jurisdiction over Defendant because, upon
`
`information and belief, it regularly and continuously transacts business in the State of Utah.
`
`7.
`
`Venue is proper in the United States District Court for the Central District of Utah
`
`pursuant to 28 U.S.C. § 1391(b) because, upon information and belief, Defendant has regularly
`
`and continuously transacted business within the State of Utah.
`
`
`
`-2-
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 3 of 7
`
`GENERAL ALLEGATIONS
`
`Background on Plaintiffs’ Business
`
`
`
`8.
`
`Nutraceutical (directly and through its subsidiaries) manufactures, distributes, and
`
`sells a wide variety of nutritional and dietary supplements, cosmetic products, and therapeutic
`
`topical products in health and natural food stores and similar outlets nationwide.
`
`9.
`
`NutraMarks is a wholly-owned subsidiary of Nutraceutical and owns the
`
`trademark rights to the ALKAMAX trademark at issue.
`
`10.
`
`Since at least as early as 2002, Nutraceutical and its predecessors have used the
`
`ALKAMAX mark in commerce throughout the United States in connection with the advertising
`
`and sale of an “alkaline booster” nutritional supplement product.
`
`11.
`
`On February 21, 2011, Plaintiffs’ predecessor filed an application to register the
`
`ALKAMAX mark with the United States Patent and Trademark Office (“USPTO”) for “dietary
`
`and nutritional supplements.”
`
`12.
`
`The trademark application was duly examined by a Trademark Examiner at the
`
`USPTO, who inter alia searched the USPTO records to determine whether any other registered
`
`mark presented a likelihood of confusion with the ALKAMAX mark.
`
`13.
`
`On May 2, 2012, the USPTO approved the ALKAMAX application for
`
`registration and, pursuant to 15 U.S.C. § 1062(a), published the mark for opposition. Having
`
`received no objection or opposition within the prescribed period, on August 7, 2012, the USPTO
`
`registered the mark AKLAMAX for “dietary and nutritional supplements” in International Class
`
`5. A copy of NutraMarks’ trademark registration for ALKAMAX is filed herewith as Exhibit 1.
`
`
`
`
`
`-3-
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 4 of 7
`
`Background on Defendant
`
`14.
`
`Upon information and belief, Bayer is a wholly-owned subsidiary of Bayer AG, a
`
`German corporation, which is global enterprise specializing in the fields of health care, nutrition,
`
`crop science, and high-tech materials.
`
`15.
`
`Upon information and belief, Bayer uses the name ALKA-SELTZER in
`
`connection with the advertising and sale of “over the counter” (OTC) antacid effervescent and
`
`pain reliever products.
`
`16.
`
`Upon information and belief, Bayer is the owner of several U.S. Trademark
`
`Registrations for the mark ALKA-SELTZER for antacid effervescent preparations, pain
`
`relievers, and dietary supplements.
`
`Defendant Seeks to Cancel NutraMarks’ Trademark Registration
`
`On September 13, 2013, Bayer filed a Petition for Cancellation with the
`
`17.
`
`Trademark Trial and Appeal Board (“TTAB”) seeking to cancel NutraMarks’ trademark
`
`registration for the ALKAMAX. Notwithstanding the Trademark Examiner’s contrary view of
`
`the matter, Bayer asserted that NutraMarks’ use of the ALKAMAX mark is likely to cause
`
`confusion, mistake, and/or deception with Bayer’s ALKA-SELTZER mark, and that Bayer will
`
`be damaged by the continued registration of the ALKAMAX mark for the goods identified in the
`
`registration. A copy of Bayer’s September 13, 2013 Petition for Cancellation is attached as
`
`Exhibit 2.
`
`18.
`
`Based on its Petition for Cancellation, Bayer maintains that a likelihood of
`
`confusion exists between Plaintiffs’ ALKAMAX product and Bayer’s ALKA-SELTZER
`
`product, which constitutes trademark infringement under the Lanham Act. However, despite the
`
`
`
`-4-
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 5 of 7
`
`fact that Nutraceutical and its predecessors have sold the ALKAMAX products in the market
`
`since 2002, Bayer has taken no action to file suit or otherwise stop Plaintiffs’ use or sale of the
`
`ALKAMAX products.
`
`19.
`
`Under the circumstances, Plaintiffs possess an objectively reasonable
`
`apprehension that Bayer will file suit for trademark infringement based upon Bayer’s allegations
`
`in the Petition for Cancellation.
`
`20.
`
`Therefore, there exists an actual and justiciable controversy between NutraMarks
`
`and Bayer regarding whether Plaintiffs’ use of the ALKAMAX mark is infringing the alleged
`
`trademark rights owned by Bayer.
`
`21.
`
`Under the relevant factors for determining infringement, there is no likelihood of
`
`confusion between the parties’ respective uses of their marks. The only commonality between
`
`the marks, ALKA, is descriptive of the properties of the products. There are a multitude of third-
`
`party antacid and alkaline additive products that begin with ALKA, including ALKA CAL,
`
`ALKA CLEANSE, ALKA PRO, ALKA ZONE, and others.
`
`22.
`
`Unlike Bayer’s ALKA SELZTER product, Plaintiffs’ ALKAMAX product is not
`
`an “over the counter” (OTC) product, is not an antacid, and is not an effervescent product. On
`
`the contrary, it’s an alkaline booster/stabilizing product, classified as a dietary supplement.
`
`23.
`
`Unlike Bayer’s ALKA SELZTER product, Plaintiffs’ ALKAMAX product is not
`
`sold in mass market retail outlets, but instead is sold through health food and other natural food
`
`stores and outlets. Despite co-existing in the market for over ten years, there have been no
`
`instances of actual confusion between the products.
`
`
`
`-5-
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 6 of 7
`
`24.
`
`Plaintiffs’ right to use its ALKAMAX trademark, including the continued
`
`marketing and sale of its ALKAMAX products, is now clouded as a result of Bayer’s actions.
`
`Bayer’s allegations will continue to impede and interfere with Plaintiffs’ legitimate business
`
`interests and objectives, thereby constituting actual harm and injury to Plaintiffs.
`
`FIRST CLAIM FOR RELIEF
`(Declaratory Judgment of Non-Infringement)
`
`Plaintiffs incorporate by this reference the allegations contained in the preceding
`
`25.
`
`paragraphs of the Complaint.
`
`26.
`
`Plaintiffs do not infringe any existing and valid trademark right of Bayer in
`
`ALKA-SELTZER under the federal Lanham Act, applicable state statute, or common law.
`
`27.
`
`Plaintiffs’ use of ALKAMAX is not likely to cause confusion, mistake, or
`
`deception, or confuse the relevant public as to source, sponsorship, or affiliation with Defendant
`
`or Defendant’s use of ALKA-SELTZER.
`
`PRAYER FOR RELIEF
`
`
`
`FOR THESE REASONS, Plaintiffs pray for a judgment in their favor and against
`
`Defendant as follows:
`
`A.
`
`That the Court declare that Plaintiffs’ use of ALKAMAX is not likely to
`
`confuse consumers as to the source, sponsorship or affiliation of Plaintiffs or their
`
`ALKAMAX products;
`
`B.
`
`That the Court order that Defendant, its directors, officers, employees,
`
`servants, attorneys, agents, representatives, distributors, licensees, and all persons in
`
`active concert or participation with them, be enjoined and restrained permanently from
`
`
`
`-6-
`
`

`
`Case 2:13-cv-00955-TC Document 2 Filed 10/17/13 Page 7 of 7
`
`interfering with Plaintiffs’ use or registration of the ALKAMAX mark, including in a
`
`domain name, and from opposing or otherwise objecting or seeking to cancel any of
`
`Plaintiffs’ federal registrations or applications for ALKAMAX based upon an alleged
`
`likelihood of confusion with ALKA-SELTZER.
`
`C.
`
`D.
`
`That Plaintiffs be awarded their reasonable attorneys’ fees and costs.
`
`For such other and further relief as the Court deems appropriate.
`
`Dated: October 17, 2013.
`
`
`
`
`
`
`/s/ Mark A. Miller
`Mark A. Miller, 9563
`mmiller@hollandhart.com
`HOLLAND & HART LLP
`222 S. Main Street, Suite 2200
`Salt Lake City, UT 84101
`Telephone: (801) 799-5800
`Facsimile: (801) 799-5700
`
`Timothy P. Getzoff, (pro hac vice pending)
`tgetzoff@hollandhart.com
`HOLLAND & HART LLP
`1800 Broadway, Suite 300
`Boulder, CO 80302
`Telephone: (303) 473-2700
`Facsimile: (303) 473-2720
`
`ATTORNEYS FOR PLAINTIFFS
`NUTRACEUTICAL CORPORATION AND
`NUTRAMARKS, INC.
`
`
`
`-7-
`
`
`
`6439018_1
`
`
`
`

`
`Case 2:13-cv-00955-TC Document 2-1 Filed 10/17/13 Page 1 of 3
`
`Exhibit 1
`
`
`
`

`
`Case 2:13-cv-00955-TC Document 2-1 Filed 10/17/13 Page 2 of 3
`
`A1kaMax
`
`CIIRISTY, MARTHA (UNITED STATES INDIVIDUAL)
`Reg, No, 4,184,983
`1895 s LOS FELIZ DRIVE
`_
`Registered Aug. 7, 2012 TEMPE, A7, 8528] AND
`
`Int. CL: 5
`
`TRADEIVIARK
`
`CHRISTY, JOSEPH (UNITED STATES INDIVIDUAL)
`1895 S LOS FELIZ DRIVE
`TEMPE, AZ 85281
`
`PRINCIPAL REGISTER
`
`FOR: DIETARY AND NUTRITIONAL SUPPLEMENTS, IN CLASS 5 (US. CLS. 6, 18, 44, 46,
`51 AND 52).
`
`FIRST USE 5-24-2002; IN COMMERCE 5-24-2002.
`
`THE MARK CONSISTS OF STANDARD CHARACTERS WITHOUT CLAIM TO ANY PAR-
`TICULAR FONT, STYLE, SIZE, OR COLOR.
`
`SER_ NO. 85—247,318, FILED 2-21-2011.
`
`KRISTIN DAHLING, EXAMINING ATTORNEY
`
`Director uflhe Unized States Patent and I‘I'ademu1'l< (lfiice
`
`

`
`Case 2:13-cv-00955-TC Document 2-1 Filed 10/17/13 Page 3 of 3
`
`REQUIREMENTS TO MAINTAIN YOUR FEDERAL
`TRADENIARK REGISTRATION
`
`WARNIN G: YOUR REGISTRATION WILL BE CANCELLED IF YOU DO N OT FILE THE
`DOCUNIENTS BELOVV DURING THE SPECIFIED TINIE PERIODS.
`
`Requirements in the First Ten Years*
`What and When to File:
`
`First Filing Deadline: You must file a Declaration of Use (or Excusable Nonuse) between the
`5th and 6th years after the registration date. See 15 U.S.C. §§1058, 1141l<.
`If the declaration is
`accepted, the registration will continue in force for the remainder of the ten-year period, calculated
`from the registration date, unless cancelled by an order of the Commissioner for Trademarks or a
`federal court.
`
`Second Filing Deadline: You must file a Declaration of Use (or Excusable Nonuse) and em
`Application for Renewal between the 9th and 10th years after the registration date.*
`See 15 U.S.C. §l059.
`
`Requirements in Successive Ten-Year Periods*
`What and When to File:
`
`You must file a Declaration ofUse (or Excusable Nonuse) and an Application for Renewal between
`every 9th and 10th-year period, calculated from the registration date.*
`
`Grace Period Filings*
`
`The above documents will be accepted as timely if filed within six months after the deadlines listed above
`with the payment of an additional fee.
`
`*ATTENTION MADRID PROTOCOL REGISTRANTS: The holder of an international registration with
`an extension of protection to the United States under the Madrid Protocol must timely file the Declarations
`of Use (or Excusable Nonuse) referenced above directly with the USPTO. The time periods for filing are
`based on the U.S. registration date (not the international registration date). The deadlines and grace periods
`for the Declarations of Use (or Exeusable Nonuse) are identical to those for nationally issued registrations.
`See 15 U.S.C. §§1058._ 1141l<. However, owners of international registrations do not file renewal applications
`at the USPTO. Instead, the holder must file a renewal of the underlying international registration at the
`International Bureau of the World Intellectual Propelty Organization, under A lticle 7 of the Madrid Protocol,
`before the expiration of each ten-year term of protection, calculated from the date of the international
`registration. See 15 U.S.C. §1141j. For more information and renewal forms for the international registration,
`see http://www.wipo.int/madrid/ervl
`
`NOTE: Fees and requirements for maintaining registrations are subject to change. Please check the
`USPTO website for further information. With the exception of renewal applications for registered
`extensions ofprotection, you can file the registration maintenance documents referenced above online
`at http://www.uspto.gov.
`
`Page: 2 / RN # 4,184,983
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 1 of 8
`
`Exhibit 2
`
`
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 2 of 8
`Case 2:13—cv—OO955—TC Document 2-2 Filed 10/17/13 Page 2 of 8
`
`
`
`MCAUUFFE
`DEFENDWG YOUR B®AND
`
`ELISABETH K. O'NEILL
`
`DIRECT 312-554-7974
`eonei|i@pattisha|i.com
`
`September 13, 2013
`
`?"-"'-
`
`VIA FERST CIASS MAIL
`
`ti
`
`:
`
`it
`
`NUTRAMARKS, INC.
`1500 Kearns Boulevard, Suite B200
`Park City, Utah 84060
`
`Re:
`
`Bayer Healthcare LLC v. Nutramarks. Inc.
`
`To Whom It May Concern:
`
`Please see attached Petition for Cancellation regarding the above matter.
`
`Sincerely,
`
`I
`
`—e,urQ
`
`EO:rm
`
`Enclosure
`
` PATFISHALL
`
`
`
`MCAULIFFE
`NEWBURY
`HILLIARD &
`
`GERALDSON LLP 0 200 South Wacker Drive. Suite 2900 0 Chicago. iL 60606- 5896 D T (312) 554-8000 0 F (312) 554-8015 ° www.pattis|'ia|l.com
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 3 of 8
`Case 2:13—cv—OO955—TC Document 2-2 Filed 10/17/13 Page 3 of 8
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`TRADEMARK TRIAL AND APPEAL BOARD
`
`In the Matter of Registration No. 4,184,983: ALKAMAX
`
`Date of Issue: August 7, 2012
`
`BAYER HEALTHCARE LLC,
`
`Petitioner,
`
`v.
`
`NUTRAMARKS, INC.
`
`Registrant.
`
`\../\._/\-.-/‘I-—/\.J%/\..d'\u_/\-—-4
`
`Cancellation No.
`
`PETITION FOR CANCELLATION
`
`Bayer HealthCare LLC, a Delaware limited liability company having offices at 100
`
`Bayer Road, Pittsburgh, Pennsylvania, 15205, believes it is and will continue to be damaged by
`
`the mark shown in Registration No. 4,184,983, and hereby petitions to cancel the same.
`
`The grounds for the petition are as follows:
`
`1.
`
`Since long prior to the priority date of Registration No. 4,184,983, Petitioner and
`
`its predecessors have used the mark ALKA-SELTZER in connection with the advertising and
`
`sale of antacid effervescent preparations, pain relievers, and dietary supplements.
`
`2.
`
`Petitioner owns the trademark registrations shown below, all comprised of its
`
`trademark, and all of which, except the registrations for ALKA-SELTZER (stylized), Reg. No.
`
`283,831 and ALKA-SELTZER PLUS IMMUNITY COMPLEX, are incontestable pursuant to 15
`
`U.S.C. § 1065 and 1115(b).
`
`GOODS
`
`Anti-acid effervescent
`preparations
`
`
`
`
`
`
`REG. DATE
`
`June 9, 1931
`
`
`
`
`MEI: REG. N0-
`
`
`
`ALKA-SELTZER
`
`283 831
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 4 of 8
`Case 2:13—cv—OO955—TC Document 2-2 Filed 10/17/13 Page 4 of 8
`
`
`
`ALKA-SELTZER
`
`ALKA-SELTZER PLUS
`
`
`
`
`
`E
`
`
`
`
`
`REG. NO.
`
`REG. DATE
`
`667,053
`
`September 16, 1958
`
`GOODS
`
`
`
`re arations
`Antacid analgesic
`effervescent
`re aration
`
`864,883
`1,914,472
`
`Februar 18,1969
`August 29, 1995
`
`1 ,904,060
`
`July 11, 1995
`
`Antacid and pain
`reliever
`
`Antacid and pain
`reliever
`
`
`
`
`
` Antacid and pain
`
`reliever
`
`
`
`1,904,061
`
`July 1 1, 1995
`
`ALKA-SELTZER PM
`
`2,168,388
`
`June 23, 1998
`
`ALKA_gELTzER PLUS
`IMMUNITY COMPLEX
`
`3,463,226
`
`July 9, 2008
`
`Pain reliever and
`Slee u; tablets
`Dietary supplements
`
`
`
`
`
`
`
`
`
`3.
`
`By virtue of Petitioner's and its predecessors‘ extensive sales, advertising and
`
`promotion of antacid effervescent preparations, pain relievers, and dietary supplements under
`
`their ALKA-SELTZER trademark, Petitioner and its predecessors have built up and petitioner
`
`now owns valuable goodwill symbolized by its ALKA-SELTZER trademark.
`
`4.
`
`By virtue of the aforesaid extensive sales, advertising and promotion, the ALKA-
`
`SELTZER mark is famous, and achieved that fame long prior to the priority date of Registration
`
`No. 4,184,983.
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 5 of 8
`Case 2:13—cv—OO955—TC Document 2-2 Filed 10/17/13 Page 5 of 8
`
`5.
`
`The use by Registrant of the trademark ALKAMAX for “dietary and nutritional
`
`supplements” and as a solution “to avoid over-acidity and occasional heartburn,” is likely to
`
`result in confusion with Petitioner’s ALKA-SELTZER trademark, or in the mistaken belief that
`
`Registrant or its ALKAMAX products are in some way legitimately connected with, licensed or
`
`approved by Petitioner.
`
`6.
`
`On information and belief, neither Registrant nor any predecessor or related
`
`company of Registrant has a claim of right in the mark ALKAMAX prior to May 24, 2002, the
`
`date of first use in commerce cited in the application that matured into Registration No.
`
`4,184,983.
`
`7.
`
`Registranfs use and registration of the trademark ALKAMAX are without
`
`Petitione-r’s consent or permission.
`
`WHEREFORE, registration by Registrant of ALKAMAX for the aforesaid goods is
`
`damaging to Petitioner and Petitioner prays for cancellation of Registration No. 4,184,983.
`
`Petitioner herein has submitted the requisite filing fee in the amount of $300. Please
`
`debit any deficiency or credit any overpayment to, Deposit Account No. 16-0650.
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 6 of 8
`Case 2:13—cv—OO955—TC Document 2-2 Filed 10/17/13 Page 6 of 8
`
`Please address all correspondence to Phillip Barengolts, Pattishall, McAuIiffe, Newbury,
`
`Hilliard & Geraldson LLP, 200 South Wacker Drive, Suite 2900, Chicago, Illinois 60606.
`
`Date: September 13, 2013
`
`PATTISHALL, MCAULIFFE, NEWBURY,
`HILLIARD & GERALDSON LLP
`
`/Elisabeth K. O’Neill/
`By
`Phillip Barengolts
`Elisabeth K. O’Nei1l
`
`200 South Wacker Drive
`Suite 2900
`
`Chicago, Illinois 60606
`(312) 554-8000
`
`Attorneys for Bayer HealthCa.re LLC
`
`

`
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 7 of 8
`Case 2:13-cv—OO955—TC Document 2-2 Filed 10/17/13 Page 7 Of 8
`
`(
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a copy ofthe foregoing PETITION FOR CANCELLATION was
`served by first-class mail on September 13, 2013, upon the following:
`
`NUTRAMARKS, INC.
`1500 KEARNS BOULEVARD, SUITE B200
`PARK CITY, UTAH 84060
`
`*
`
`/Elisabeth K. O'Neill/
`
`/Elisabeth K. O'NeiIl/
`
`

`
`7..2tnemUCODCT.559OmuV
`l71l.01dP.
`._H
`Case 2:13-cv-00955-TC Document 2-2 Filed 10/17/13 Page 8 of 8
`
`>._4._mI>_._.
`
`z_n>c_._m_nm
`
`
`
`
`
`omnmzgzm<0cxu@>2u
`
`Moomac»:$5202.3a33~25anrfimma.F3o8.mm§
`
`
`
`zc,:ca.<.7/.0.
`
`
`
`GooWn8:m.mo:F,<B.m.max£8E;05:G8:$58
`
`$3
`
`waamaqwwnmo
`
`.._=u.=.—2.=:——=_..?—_——._.?—___—.~—ZT=?.._.=-1....
`
`
`
`

`
`-6  5HY 

`
`Case 2:13-cv-00955-TC Document 2-3 Filed 10/17/13 Page 1 of 2
` CIVIL COVER SHEET
`7KH -6  FLYLO FRYHU VKHHW DQG WKH LQIRUPDWLRQ FRQWDLQHG KHUHLQ QHLWKHU UHSODFH QRU VXSSOHPHQW WKH ILOLQJ DQG VHUYLFH RI SOHDGLQJV RU RWKHU SDSHUV DV UHTXLUHG E\ ODZ H[FHSW DV
`SURYLGHG E\ ORFDO UXOHV RI FRXUW 7KLV IRUP DSSURYHG E\ WKH -XGLFLDO &RQIHUHQFH RI WKH 8QLWHG 6WDWHV LQ 6HSWHPEHU  LV UHTXLUHG IRU WKH XVH RI WKH &OHUN RI &RXUW IRU WKH
`SXUSRVH RI LQLWLDWLQJ WKH FLYLO GRFNHW VKHHW (SEE INSTRUCTIONS ON NEXT PAGE OF THIS FORM.)
`
`I. (a) PLAINTIFFS
`NUTRACEUTICAL CORPORATION, a Delaware corporation, and
`NUTRAMARKS, INC., a Delaware corporation,
`
`DEFENDANTS
`BAYER HEALTHCARE LLC, a Delaware limited liability company,
`
`(b) &RXQW\ RI 5HVLGHQFH RI )LUVW /LVWHG 3ODLQWLII
`
`Summit
`(EXCEPT IN U.S. PLAINTIFF CASES)
`
`(c) $WWRUQH\V (Firm Name, Address, and Telephone Number)
`Holland & Hart LLP, Mark A. Miller and Timothy P. Getzoff, pro hac vice
`222 S. Main Street, Suite 2200, Salt Lake City, UT 84101, and
`1800 Broadway, Suite 300, Boulder, CO 80302
`
`&RXQW\ RI 5HVLGHQFH RI )LUVW /LVWHG 'HIHQGDQW
`
`(IN U.S. PLAINTIFF CASES ONLY)
`
`127(
`
`,1 /$1' &21'(01$7,21 &$6(6 86( 7+( /2&$7,21 2)
`7+( 75$&7 2) /$1' ,192/9('
`
` $WWRUQH\V (If Known)
`
`II. BASIS OF JURISDICTION (Place an “X” in One Box Only)
`
`u  86 *RYHUQPHQW
`3ODLQWLII
`
`u  )HGHUDO 4XHVWLRQ
`(U.S. Government Not a Party)
`
`III. CITIZENSHIP OF PRINCIPAL PARTIES (Place an “X” in One Box for Plaintiff
`(For Diversity Cases Only)
` and One Box for Defendant)
` PTF DEF
` PTF
` DEF
`u 
`u 
`u 
`u 
`,QFRUSRUDWHG or 3ULQFLSDO 3ODFH
`&LWL]HQ RI 7KLV 6WDWH
` RI %XVLQHVV ,Q 7KLV 6WDWH
`
`u  86 *RYHUQPHQW
`'HIHQGDQW
`
`u  'LYHUVLW\
`(Indicate Citizenship of Parties in Item III)
`
`&LWL]HQ RI $QRWKHU 6WDWH
`
`u 
`
`u 
`
`,QFRUSRUDWHG and 3ULQFLSDO 3ODFH
`RI %XVLQHVV ,Q $QRWKHU 6WDWH
`
`u 
`
`u 
`
`IV. NATURE OF SUIT (Place an “X” in One Box Only)
`CONTRACT
`TORTS
`
`&LWL]HQ RU 6XEMHFW RI D
` )RUHLJQ &RXQWU\
`
`u 
`
`u 
`
`)RUHLJQ 1DWLRQ
`
`u 
`
`u 
`
`FORFEITURE/PENALTY
`
`BANKRUPTCY
`
`OTHER STATUTES
`
`u  ,QVXUDQFH
` PERSONAL INJURY
` PERSONAL INJURY
`u  3HUVRQDO ,QMXU\ 
`u  $LUSODQH
`u  0DULQH
`u  $LUSODQH 3URGXFW
`u  0LOOHU $FW
` 3URGXFW /LDELOLW\
`u  +HDOWK &DUH
`u  1HJRWLDEOH ,QVWUXPHQW
` /LDELOLW\
`u  5HFRYHU\ RI 2YHUSD\PHQW u  $VVDXOW /LEHO
` 3KDUPDFHXWLFDO
` 3HUVRQDO ,QMXU\
` (QIRUFHPHQW RI -XGJPHQW
` 6ODQGHU
`u  0HGLFDUH $FW
`u  )HGHUDO (PSOR\HUV¶
` 3URGXFW /LDELOLW\
`u  $VEHVWRV 3HUVRQDO
`u  5HFRYHU\ RI 'HIDXOWHG
` /LDELOLW\
`u  0DULQH
` ,QMXU\ 3URGXFW
` 6WXGHQW /RDQV
`u  0DULQH 3URGXFW
` /LDELOLW\
` ([FOXGHV 9HWHUDQV

`LABOR
` PERSONAL PROPERTY u  )DLU /DERU 6WDQGDUGV
`u  5HFRYHU\ RI 2YHUSD\PHQW
` /LDELOLW\
`u  2WKHU )UDXG
`u  0RWRU 9HKLFOH
` $FW
` RI 9HWHUDQ¶V %HQHILWV
`u  7UXWK LQ /HQGLQJ
`u  6WRFNKROGHUV¶ 6XLWV
`u  0RWRU 9HKLFOH
`u  /DERU0DQDJHPHQW
`u  2WKHU &RQWUDFW
`u  2WKHU 3HUVRQDO
` 3URGXFW /LDELOLW\
` 5HODWLRQV
`u  5DLOZD\ /DERU $FW
`u  &RQWUDFW 3URGXFW /LDELOLW\ u  2WKHU 3HUVRQDO
` 3URSHUW\ 'DPDJH
`u  3URSHUW\ 'DPDJH
`u  )DPLO\ DQG 0HGLFDO
`u  )UDQFKLVH
` ,QMXU\
`u  3HUVRQDO ,QMXU\ 
` 3URGXFW /LDELOLW\
` /HDYH $FW
`u  2WKHU /DERU /LWLJDWLRQ
` 0HGLFDO 0DOSUDFWLFH
` PRISONER PETITIONS u  (PSOR\HH 5HWLUHPHQW
` CIVIL RIGHTS
`u  2WKHU &LYLO 5LJKWV
` ,QFRPH 6HFXULW\ $FW
`Habeas Corpus:
`u  $OLHQ 'HWDLQHH
`u  9RWLQJ
`u  0RWLRQV WR 9DFDWH
`u  (PSOR\PHQW
`u  +RXVLQJ
` 6HQWHQFH
`u  *HQHUDO
` $FFRPPRGDWLRQV
`u  $PHU Z'LVDELOLWLHV  u  'HDWK 3HQDOW\
` (PSOR\PHQW
`Other:
`u  $PHU Z'LVDELOLWLHV  u  0DQGDPXV 2WKHU
`u  &LYLO 5LJKWV
` 2WKHU
`u  (GXFDWLRQ
`u  3ULVRQ &RQGLWLRQ
`u  &LYLO 'HWDLQHH 
` &RQGLWLRQV RI
` &RQILQHPHQW
`
`u  $SSHDO  86& 
`u  'UXJ 5HODWHG 6HL]XUH
` RI 3URSHUW\  86&  u  :LWKGUDZDO
`u  2WKHU
`  86& 
`
`u  )DOVH &ODLPV $FW
`u  6WDWH 5HDSSRUWLRQPHQW
`u  $QWLWUXVW
`u  %DQNV DQG %DQNLQJ
`u  &RPPHUFH
`u  'HSRUWDWLRQ
`u  5DFNHWHHU ,QIOXHQFHG DQG
` &RUUXSW 2UJDQL]DWLRQV
`u  &RQVXPHU &UHGLW
`u  &DEOH6DW 79
`u  6HFXULWLHV&RPPRGLWLHV
` ([FKDQJH
`u  2WKHU 6WDWXWRU\ $FWLRQV
`u  $JULFXOWXUDO $FWV
`u  (QYLURQPHQWDO 0DWWHUV
`u  )UHHGRP RI ,QIRUPDWLRQ
` $FW
`u  $UELWUDWLRQ
`u  $GPLQLVWUDWLYH 3URFHGXUH
` $FW5HYLHZ RU $SSHDO RI
` $JHQF\ 'HFLVLRQ
`u  &RQVWLWXWLRQDOLW\ RI
` 6WDWH 6WDWXWHV
`
`PROPERTY RIGHTS
`u  &RS\ULJKWV
`u  3DWHQW
`u  7UDGHPDUN
`
`SOCIAL SECURITY
`u  +,$ II

`u  %ODFN /XQJ 

`u  ',:&',:: J

`u  66,' 7LWOH ;9,
`u  56, J

`
`FEDERAL TAX SUITS
`u  7D[HV 86 3ODLQWLII
` RU 'HIHQGDQW

`u  ,56²7KLUG 3DUW\
`  86& 
`
`IMMIGRATION
`u  1DWXUDOL]DWLRQ $SSOLFDWLRQ
`u  2WKHU ,PPLJUDWLRQ
` $FWLRQV
`
` REAL PROPERTY
`u  /DQG &RQGHPQDWLRQ
`u  )RUHFORVXUH
`u  5HQW /HDVH (MHFWPHQW
`u  7RUWV WR /DQG
`u  7RUW 3URGXFW /LDELOLW\
`u  $OO 2WKHU 5HDO 3URSHUW\
`
`V. ORIGIN (Place an “X” in One Box Only)
`u  2ULJLQDO
`u  5HPRYHG IURP
`3URFHHGLQJ
`6WDWH &RXUW
`
`u  5HPDQGHG IURP
`$SSHOODWH &RXUW
`
`u  5HLQVWDWHG RU
`5HRSHQHG
`
`u  0XOWLGLVWULFW
`/LWLJDWLRQ
`
`u  7UDQVIHUUHG IURP
`$QRWKHU 'LVWULFW
`(specify)
`&LWH WKH 86 &LYLO 6WDWXWH XQGHU ZKLFK \RX DUH ILOLQJ (Do not cite jurisdictional statutes unless diversity)
`28 U.S.C. sections 2201-2202; 15 U.S.C. section 1051, et seq.
`ULHI GHVFULSWLRQ RI FDXVH
`Declaratory Judgment of Non-Infringement
`u &+(&. ,) 7+,6 ,6 $ CLASS ACTION
`81'(5 58/(  )5&Y3
`
`DEMAND $
`
`&+(&. <(6 RQO\ LI GHPDQGHG LQ FRPSODLQW
`u <HV
`u 1R
`
`JURY DEMAND:
`
`(See instructions):
`
`-8'*(
`
`'2&.(7 180%(5
`
`6,*1$785( 2) $77251(< 2) 5(&25'
`/s/ Mark A. Miller
`
` %
`
`VI. CAUSE OF ACTION
`
`VII. REQUESTED IN
` COMPLAINT:
`
`VIII. RELATED CASE(S)
` IF ANY
`
`'$7(
`10/17/2013
`FOR OFFICE USE ONLY
`
`5(&(,37 
`
`$02817
`
`$33/<,1* ,)3
`
`-8'*(
`
`0$* -8'*(
`
`

`
`-6  5HYHUVH 5HY 

`
`Case 2:13-cv-00955-TC Document 2-3 Filed 10/17/13 Page 2 of 2
`
`INSTRUCTIONS FOR ATTORNEYS COMPLETING CIVIL COVER SHEET FORM JS 44
`
`$XWKRULW\ )RU &LYLO &RYHU 6KHHW
`
`7KH -6  FLYLO FRYHU VKHHW DQG WKH LQIRUPDWLRQ FRQWDLQHG KHUHLQ QHLWKHU UHSODFHV QRU VXSSOHPHQWV WKH ILOLQJV DQG VHUYLFH RI SOHDGLQJ RU RWKHU SDSHUV DV
`UHTXLUHG E\ ODZ H[FHSW DV SURYLGHG E\ ORFDO UXOHV RI FRXUW 7KLV IRUP